Search Results - Yonghai Peng

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Preliminary study on BRICS sequential therapeutic regimen as salvage treatment for refractory advanced colorectal cancer patients harboring pMMR status by Yonghai Peng, Jian Wang, Junhui Wang, Jianxin Chen

    Published in Frontiers in Immunology (2025-09-01)
    Get full text
    Article


  2. 2

    Commentary: Association between triglyceride glucose-body mass index and 365-day mortality in patients with critical coronary heart disease by Yonghai Peng, Ruizi Shi, Decai Wang, Xintao Zeng, Jianjun Wang

    Published in Frontiers in Endocrinology (2025-06-01)
    Get full text
    Article


  3. 3

    HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein. by Jianfang Chen, Zhenyu Ding, Yonghai Peng, Feng Pan, Jianjun Li, Lan Zou, Yanling Zhang, Houjie Liang

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  4. 4

    Prognostic value of albumin-corrected anion gap in critically ill patients with sepsis-associated liver injury: a retrospective study by Jianjun Wang, Yonghai Peng, Zhaohui Hu, Xi Chen, Sirui Chen, Pei Yang, Xintao Zeng, Decai Wang

    Published in BMC Infectious Diseases (2025-07-01)
    Get full text
    Article


  5. 5

    Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study by Yongbiao Chen, Hanyin Hong, Wenzheng Fang, Xia Zhang, Huachun Luo, Zhijian Chen, Jianda Yu, Weiqiang Fan, Xiaobin Chi, Yonghai Peng

    Published in Frontiers in Oncology (2023-03-01)
    Get full text
    Article


  6. 6

    Relative fat mass and risk of metabolic dysfunction associated steatotic liver disease and severe hepatic steatosis in U.S. adults: analysis of NHANES 2017–2020 data by Jianjun Wang, Wei He, Xianfu Cai, Zhaohui Hu, Yonghai Peng, Xi Chen, Pei Yang, Xintao Zeng, Sirui Chen, Decai Wang

    Published in BMC Gastroenterology (2025-05-01)
    Get full text
    Article


  7. 7

    BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective... by Jianxin Chen, Jian Wang, Jian Wang, Weiqiang Fang, Yating Wu, Hang Li, Hui Xu, Yunyun Zhu, Yanran Cheng, Zongyang Yu, Yonghai Peng

    Published in Frontiers in Immunology (2025-06-01)
    Get full text
    Article


  8. 8

    Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs by Tingting Lin, Qun Ren, Weimin Zuo, Ruxue Jia, Linhui Xie, Rong Lin, Hu Zhao, Jin Chen, Yan Lei, Ping Wang, Huiyue Dong, Lianghu Huang, Jinquan Cai, Yonghai Peng, Zongyang Yu, Jianming Tan, Shuiliang Wang

    Get full text
    Article


Search Tools: